These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 22964022)
1. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022 [TBL] [Abstract][Full Text] [Related]
2. Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Cabello-Verrugio C; Acuña MJ; Morales MG; Becerra A; Simon F; Brandan E Biochem Biophys Res Commun; 2011 Jul; 410(3):665-70. PubMed ID: 21693104 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts. Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700 [TBL] [Abstract][Full Text] [Related]
6. The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle. Morales MG; Abrigo J; Meneses C; Simon F; Cisternas F; Rivera JC; Vazquez Y; Cabello-Verrugio C Clin Sci (Lond); 2014 Aug; 127(4):251-64. PubMed ID: 24588264 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415 [TBL] [Abstract][Full Text] [Related]
8. Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1. Kim YH; Ryu JM; Lee YJ; Han HJ J Cell Physiol; 2010 May; 223(2):397-407. PubMed ID: 20112290 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Naito T; Masaki T; Nikolic-Paterson DJ; Tanji C; Yorioka N; Kohno N Am J Physiol Renal Physiol; 2004 Feb; 286(2):F278-87. PubMed ID: 14583433 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation. Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies. Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced differentiation of adipose tissue-derived mesenchymal stem cells to smooth muscle-like cells. Kim YM; Jeon ES; Kim MR; Jho SK; Ryu SW; Kim JH Int J Biochem Cell Biol; 2008; 40(11):2482-91. PubMed ID: 18571460 [TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022 [TBL] [Abstract][Full Text] [Related]
15. Apocynin inhibits the upregulation of TGF-β1 expression and ROS production induced by TGF-β in skeletal muscle cells. Abrigo J; Morales MG; Simon F; Cabrera D; Di Capua G; Cabello-Verrugio C Phytomedicine; 2015 Sep; 22(10):885-93. PubMed ID: 26321737 [TBL] [Abstract][Full Text] [Related]
16. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells. Rhyu DY; Park J; Sharma BR; Ha H Transplant Proc; 2012 Apr; 44(3):625-8. PubMed ID: 22483454 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Gao X; He X; Luo B; Peng L; Lin J; Zuo Z Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881 [TBL] [Abstract][Full Text] [Related]
18. Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Liu JJ; Li DL; Zhou J; Sun L; Zhao M; Kong SS; Wang YH; Yu XJ; Zhou J; Zang WJ Apoptosis; 2011 Jan; 16(1):94-103. PubMed ID: 20963497 [TBL] [Abstract][Full Text] [Related]
19. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Touyz RM; Yao G; Quinn MT; Pagano PJ; Schiffrin EL Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):512-8. PubMed ID: 15618548 [TBL] [Abstract][Full Text] [Related]
20. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]